NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
02/06/2026
Voltar para busca
Dado oficial do USPTO
STABOLY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
02/06/2026
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
26/06/2024
Data de registro
02/06/2026
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/06/2026
Última transação
02/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
30/10/2025
Primeiro uso no comércio
30/10/2025
Código do desenho
4
Tipo de titular
03
Localização do titular
Staad, CH
Examinador
ZAVALA DIEK, JOSEPH MARCO
Unidade examinadora
M80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Biosynth AG
Representantes
Tara Reedy Sliva Dentons US LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Biochemicals and organic chemicals used as enzyme substratesenzyme inducersaminoglutethimidescarbamazepinesgriseofulvinsprimidonesenzyme inactivatorscultural medium additives for scientific and research use in the field of microbiology and molecular biology; biochemical and organic chemicals for use in the manufacture of pharmaceuticals and cosmetics; Chemical reagents for medical research use in the field of immunology; Chemical reagents for medical laboratory analysis research purposesfor use as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms
Classe 5
Medicinal preparationsphotosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical usefor the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposesfor Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosiscoronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposesfor novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communitiesfor medical treatment purpose and diagnostic use; Organic chemical preparations for medical purposesimmunomodulators with anti-inflammatory properties for treating blood disordersautoimmune diseasesallergic conditions; Organic chemical preparations and enzymes for medical laboratory diagnostic analysis purposesfor medical detectionidentification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory diagnostic analysis purposesfor medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposesfor medical detection of pathogenic bacteriavarious strains of ListeriaClostridiumBacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposesfor the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococcus aureusin particular for Methicillin-resistant Staphylococcus aureus (MRSA); biochemical and organic chemical reagents for clinical diagnostic laboratory use
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
02/06/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/05/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/05/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/05/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/05/2026
ALIE
ASSIGNED TO LIE
04/05/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/04/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/04/2026
GNRT
NON-FINAL ACTION E-MAILED
13/04/2026
CNRT
SU - NON-FINAL ACTION - WRITTEN
13/04/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
11/04/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/04/2026
IUAF
USE AMENDMENT FILED
31/10/2025
EISU
TEAS STATEMENT OF USE RECEIVED
31/10/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
27/05/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/04/2025
PUBO
PUBLISHED FOR OPPOSITION
01/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
26/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/02/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/02/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/02/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/01/2025
GNRT
NON-FINAL ACTION E-MAILED
22/01/2025
CNRT
NON-FINAL ACTION WRITTEN
22/01/2025
DOCK
ASSIGNED TO EXAMINER
21/01/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/01/2025
NWAP
NEW APPLICATION ENTERED
26/06/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace STABOLY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.